297 related articles for article (PubMed ID: 15994933)
1. Identification of a novel c-Myc protein interactor, JPO2, with transforming activity in medulloblastoma cells.
Huang A; Ho CS; Ponzielli R; Barsyte-Lovejoy D; Bouffet E; Picard D; Hawkins CE; Penn LZ
Cancer Res; 2005 Jul; 65(13):5607-19. PubMed ID: 15994933
[TBL] [Abstract][Full Text] [Related]
2. Silencing of thrombospondin-1 is critical for myc-induced metastatic phenotypes in medulloblastoma.
Zhou L; Picard D; Ra YS; Li M; Northcott PA; Hu Y; Stearns D; Hawkins C; Taylor MD; Rutka J; Der SD; Huang A
Cancer Res; 2010 Oct; 70(20):8199-210. PubMed ID: 20876797
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional co-activator p75 binds and tethers the Myc-interacting protein JPO2 to chromatin.
Maertens GN; Cherepanov P; Engelman A
J Cell Sci; 2006 Jun; 119(Pt 12):2563-71. PubMed ID: 16735438
[TBL] [Abstract][Full Text] [Related]
4. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
Choe C; Chen N; Sawadogo M
Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
[TBL] [Abstract][Full Text] [Related]
5. Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation.
Chen H; Liu J; Zhao CQ; Diwan BA; Merrick BA; Waalkes MP
Toxicol Appl Pharmacol; 2001 Sep; 175(3):260-8. PubMed ID: 11559025
[TBL] [Abstract][Full Text] [Related]
6. Bin1 functionally interacts with Myc and inhibits cell proliferation via multiple mechanisms.
Elliott K; Sakamuro D; Basu A; Du W; Wunner W; Staller P; Gaubatz S; Zhang H; Prochownik E; Eilers M; Prendergast GC
Oncogene; 1999 Jun; 18(24):3564-73. PubMed ID: 10380878
[TBL] [Abstract][Full Text] [Related]
7. BRCA1 binds c-Myc and inhibits its transcriptional and transforming activity in cells.
Wang Q; Zhang H; Kajino K; Greene MI
Oncogene; 1998 Oct; 17(15):1939-48. PubMed ID: 9788437
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism.
Kinney EL; Tanida S; Rodrigue AA; Johnson JK; Tompkins VS; Sakamuro D
J Cell Physiol; 2008 Sep; 216(3):621-31. PubMed ID: 18348166
[TBL] [Abstract][Full Text] [Related]
9. Mmip-2, a novel RING finger protein that interacts with mad members of the Myc oncoprotein network.
Yin XY; Gupta K; Han WP; Levitan ES; Prochownik EV
Oncogene; 1999 Nov; 18(48):6621-34. PubMed ID: 10597267
[TBL] [Abstract][Full Text] [Related]
10. Functional analysis of the carboxy-terminal transforming region of v-Myc: binding to Max is necessary, but not sufficient, for cellular transformation.
Min S; Mascarenhas NT; Taparowsky EJ
Oncogene; 1993 Oct; 8(10):2691-701. PubMed ID: 8378081
[TBL] [Abstract][Full Text] [Related]
11. A structure-based model of the c-Myc/Bin1 protein interaction shows alternative splicing of Bin1 and c-Myc phosphorylation are key binding determinants.
Pineda-Lucena A; Ho CS; Mao DY; Sheng Y; Laister RC; Muhandiram R; Lu Y; Seet BT; Katz S; Szyperski T; Penn LZ; Arrowsmith CH
J Mol Biol; 2005 Aug; 351(1):182-94. PubMed ID: 15992821
[TBL] [Abstract][Full Text] [Related]
12. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer.
Buck A; Buchholz M; Wagner M; Adler G; Gress T; Ellenrieder V
Mol Cancer Res; 2006 Nov; 4(11):861-72. PubMed ID: 17114344
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation sites mapping in the N-terminal domain of c-myc modulate its transforming potential.
Henriksson M; Bakardjiev A; Klein G; Lüscher B
Oncogene; 1993 Dec; 8(12):3199-209. PubMed ID: 8247524
[TBL] [Abstract][Full Text] [Related]
14. c-myc overexpression causes anaplasia in medulloblastoma.
Stearns D; Chaudhry A; Abel TW; Burger PC; Dang CV; Eberhart CG
Cancer Res; 2006 Jan; 66(2):673-81. PubMed ID: 16423996
[TBL] [Abstract][Full Text] [Related]
15. TOJ3, a target of the v-Jun transcription factor, encodes a protein with transforming activity related to human microspherule protein 1 (MCRS1).
Bader AG; Schneider ML; Bister K; Hartl M
Oncogene; 2001 Nov; 20(51):7524-35. PubMed ID: 11709724
[TBL] [Abstract][Full Text] [Related]
16. Differential interaction of HIV-1 integrase and JPO2 with the C terminus of LEDGF/p75.
Bartholomeeusen K; De Rijck J; Busschots K; Desender L; Gijsbers R; Emiliani S; Benarous R; Debyser Z; Christ F
J Mol Biol; 2007 Sep; 372(2):407-21. PubMed ID: 17669426
[TBL] [Abstract][Full Text] [Related]
17. The human trithorax protein hASH2 functions as an oncoprotein.
Lüscher-Firzlaff J; Gawlista I; Vervoorts J; Kapelle K; Braunschweig T; Walsemann G; Rodgarkia-Schamberger C; Schuchlautz H; Dreschers S; Kremmer E; Lilischkis R; Cerni C; Wellmann A; Lüscher B
Cancer Res; 2008 Feb; 68(3):749-58. PubMed ID: 18245475
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-induced apoptosis through activation of nuclear factor-kappaB in murine hepatocellular carcinomas.
Cavin LG; Wang F; Factor VM; Kaur S; Venkatraman M; Thorgeirsson SS; Arsura M
Mol Cancer Res; 2005 Jul; 3(7):403-12. PubMed ID: 16046551
[TBL] [Abstract][Full Text] [Related]
19. Cdc25 cell-cycle phosphatase as a target of c-myc.
Galaktionov K; Chen X; Beach D
Nature; 1996 Aug; 382(6591):511-7. PubMed ID: 8700224
[TBL] [Abstract][Full Text] [Related]
20. Functional analysis of the N-terminal domain of the Myc oncoprotein.
Oster SK; Mao DY; Kennedy J; Penn LZ
Oncogene; 2003 Apr; 22(13):1998-2010. PubMed ID: 12673205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]